Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study

Published: 11/06/2024

… Diabetic foot ulcer (DFU) is a common and highly morbid complication of
diabetes with high unmet medical needs. AUP1602-C, a topical four-in-one gene therapy …